Keywords: |
cancer recurrence; conference paper; disease marker; cancer adjuvant therapy; cancer radiotherapy; nuclear magnetic resonance imaging; follow up; ki 67 antigen; protein bcl 2; neoplasm recurrence, local; mastectomy; radiotherapy; diagnostic approach route; practice guideline; tumor biopsy; breast neoplasms; breast reconstruction; protein p53; tumor marker; axillary lymph node; tumor suppressor gene; mammography; breast carcinoma; carcinoma in situ; cancer epidemiology; estrogen receptor; progesterone receptor; aspiration biopsy; frozen section; cancer scintiscanning; protein p21; intraductal carcinoma; carcinoma, intraductal, noninfiltrating; oncogene neu; humans; female
|